A prospective, single-arm, multicenter clinical study of cadonilimab combined with surufatinib in the treatment of progress advanced soft tissue sarcoma after system chemotherapy
Non targeted metabonomics study of heart failure based on UHPLC-QTOF/MS and the study on the pathogenesis of heart failure
100 项与 上海同仁药业股份有限公司 相关的临床结果
0 项与 上海同仁药业股份有限公司 相关的专利(医药)
100 项与 上海同仁药业股份有限公司 相关的药物交易
100 项与 上海同仁药业股份有限公司 相关的转化医学